ClinicalTrials.gg
Drug

Insulin clinical trials

Also written LY041001.

A group of medicines. Insulin, Regular, Human (127 studies) is counted on its own page; this page counts the studies that name Insulin itself.

studies test it
272
open now
24
in phase 3
41
first study started
1994

How each study uses Insulin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Insulin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Insulin
151
Intranasal Insulin
31
Regular Insulin
16
Oral Insulin
15
Subcutaneous Insulin
9

Development codes

LY041001
2

In one entry with another drug

Given together, or one or the other

Pioglitazone and insulin
2

Medicines filed under Insulin

As reviewed, so not every one. Each counts its studies on its own page, not here.

Studies by the year they started

268 studies that test it; most in 2016 (19)

Studies that test Insulin, by start year
YearStudies
19941
19951
19961
19971
20003
20012
20023
20036
20045
20059
200611
200713
200812
20099
201010
201112
20126
201318
201412
20159
201619
20179
201814
201911
202010
202112
202211
202310
202413
20256
20269

By phase

A phase 1/2 study counts in both.

Early Phase 1
13
Phase 1
35
Phase 2
67
Phase 3
41
Phase 4
62
No phase
70

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 47 · Other 225

Pfizer (11) · Wake Forest University Health Sciences (7) · Cairo University (6) · Institut de Recherches Cliniques de Montreal (6) · Oramed, Ltd. (5) · University of Campania Luigi Vanvitelli (5) · University Health Network, Toronto (5) · Technical University of Munich (4)

Often tested with

Tested in the same studies.

Metformin (16) · Insulin Glargine (5) · Glucose (5) · Insulin Lispro (5) · Sitagliptin (4) · Insulin Aspart (3) · Glyburide (3) · Insulin glulisine (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8

Studies that test Insulin.

Studies

Open first, then newest update. How each study uses Insulin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 272

See all 272 studies that test Insulin →

Given beside what is tested · 64 — Insulin is usual care or a partner of the new treatment

Showing 20 of 64.

As the comparator · 43 — what is tested is compared with Insulin

Showing 20 of 43.

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call Insulin · ClinicalTrials.gg INT007666

  • MeSH (NLM) D007328InsulinOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.